FR7819M - - Google Patents

Info

Publication number
FR7819M
FR7819M FR134155A FR134155A FR7819M FR 7819 M FR7819 M FR 7819M FR 134155 A FR134155 A FR 134155A FR 134155 A FR134155 A FR 134155A FR 7819 M FR7819 M FR 7819M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR134155A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of FR7819M publication Critical patent/FR7819M/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR134155A 1966-12-29 1968-12-28 Expired FR7819M (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60555066A 1966-12-29 1966-12-29
US84156169A 1969-07-14 1969-07-14

Publications (1)

Publication Number Publication Date
FR7819M true FR7819M (fr) 1970-05-20

Family

ID=27084980

Family Applications (1)

Application Number Title Priority Date Filing Date
FR134155A Expired FR7819M (fr) 1966-12-29 1968-12-28

Country Status (6)

Country Link
US (1) US3547999A (fr)
BE (1) BE708780A (fr)
DE (1) DE1643310A1 (fr)
FR (1) FR7819M (fr)
GB (1) GB1147379A (fr)
NL (1) NL6717807A (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3946119A (en) * 1974-12-23 1976-03-23 Sandoz, Inc. Optionally substituted α-tertiary butyl-p-phenoxybenzylamines and their use as hypolipidemic agents
US4034113A (en) * 1975-04-09 1977-07-05 Shulgin Alexander T Treatment of senile geriatric patients to restore performance
US4704407A (en) * 1984-12-20 1987-11-03 Eli Lilly And Company Soluble dobutamine salts
US8754238B2 (en) 2003-07-22 2014-06-17 Arena Pharmaceuticals, Inc. Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of disorders related thereto
US7022492B2 (en) * 2003-12-15 2006-04-04 Dade Behring Inc. Ecstasy haptens and immunogens
US6991911B2 (en) * 2003-12-15 2006-01-31 Dade Behring Inc. Assay for entactogens
US20050130243A1 (en) * 2003-12-15 2005-06-16 Zheng Yi F. Assay for entactogens
US7037669B2 (en) * 2004-03-22 2006-05-02 Dade Behring Inc. Assays for amphetamine and methamphetamine using stereospecific reagents
US7115383B2 (en) * 2004-03-22 2006-10-03 Dade Behring Inc. Assays for amphetamine and methamphetamine
EP1727803B3 (fr) 2004-03-23 2014-04-23 Arena Pharmaceuticals, Inc. Methodes de preparation de n-aryl-n'-[3-(1h-pyrazol-5-yl) phenylurees] substituees et leurs intermediaires
US8877802B2 (en) * 2005-07-28 2014-11-04 Duke Univerity Antiparkinsonian action of phenylisopropylamines
TWI415845B (zh) 2006-10-03 2013-11-21 Arena Pharm Inc 用於治療與５-ｈｔ2ａ血清素受體相關聯病症之作為５-ｈｔ2ａ血清素受體之調節劑的吡唑衍生物
JP5393677B2 (ja) 2007-08-15 2014-01-22 アリーナ ファーマシューティカルズ， インコーポレイテッド ５−ＨＴ２Ａセロトニン受容体に関連した障害の治療のための５−ＨＴ２Ａセロトニン受容体のモジュレーターとしてのイミダゾ［１，２−ａ］ピリジン誘導体
US20110021538A1 (en) 2008-04-02 2011-01-27 Arena Pharmaceuticals, Inc. Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
WO2010062321A1 (fr) 2008-10-28 2010-06-03 Arena Pharmaceuticals, Inc. Procédés utiles pour la préparation de 1-[3-(4-bromo-2-méthyl-2h-pyrazol-3-yl)-4-méthoxy-phényl]-3-(2,4-difluoro‑phényl)-urée, et formes cristallines associées
HRP20180589T1 (hr) 2008-10-28 2018-05-18 Arena Pharmaceuticals, Inc. Pripravci modulatora serotoninskog receptora 5-ht2a koji su korisni za liječenje s njim povezanih poremećaja
RU2017145976A (ru) 2015-06-12 2019-07-15 Аксовант Сайенсиз Гмбх Производные диарил- и арилгетероарилмочевины, применимые для профилактики и лечения нарушения поведения во время REM-фазы сна
TW201720439A (zh) 2015-07-15 2017-06-16 Axovant Sciences Gmbh 用於預防及治療與神經退化性疾病相關的幻覺之作為５－ｈｔ２ａ血清素受體的二芳基及芳基雜芳基脲衍生物
CA3213289A1 (fr) * 2021-03-12 2022-09-15 Gilgamesh Pharmaceuticals, Inc. Phenalkylamines et leurs procedes de fabrication et d'utilisation

Also Published As

Publication number Publication date
BE708780A (fr) 1968-07-01
DE1643310A1 (de) 1971-06-03
NL6717807A (fr) 1968-07-01
GB1147379A (en) 1969-04-02
US3547999A (en) 1970-12-15

Similar Documents

Publication Publication Date Title
FR7819M (fr)
AU424443B2 (fr)
AU428063B2 (fr)
AU421822B2 (fr)
AU6703465A (fr)
BE681061A (fr)
BE688796A (fr)
BE693815A (fr)
BE693624A (fr)
BE693004A (fr)
BE692419A (fr)
BE692412A (fr)
BE692296A (fr)
BE692227A (fr)
BE694099A (fr)
BE694206A (fr)
BE692182A (fr)
BE674882A (fr)
BE691157A (fr)
BE674987A (fr)
BE683933A (fr)
BE683128A (fr)
BE692282A (fr)
BE675173A (fr)
BE675139A (fr)